ketoconazole has been researched along with Malaria, Falciparum in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Malaria, Falciparum: Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thapar, MM | 1 |
| Ursing, J | 1 |
| Ashton, M | 1 |
| Bergqvist, Y | 1 |
| Gil, JP | 1 |
| Björkman, A | 1 |
1 other study available for ketoconazole and Malaria, Falciparum
| Article | Year |
|---|---|
Ketoconazole increases atovaquone exposure following concomitant administration with Malarone® in healthy subjects.
Topics: Antimalarials; Atovaquone; Drug Combinations; Healthy Volunteers; Humans; Ketoconazole; Malaria, Fal | 2022 |